7762 logo

Pet Pharm Biotech TPEX:7762 Stock Report

Last Price

NT$42.00

Market Cap

NT$1.7b

7D

-0.8%

1Y

n/a

Updated

28 Nov, 2024

Data

Company Financials

Pet Pharm Biotech Co., Ltd.

TPEX:7762 Stock Report

Market Cap: NT$1.7b

7762 Stock Overview

Manufactures and sells pharmaceutical products. More details

7762 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Pet Pharm Biotech Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Pet Pharm Biotech
Historical stock prices
Current Share PriceNT$42.00
52 Week HighNT$45.50
52 Week LowNT$27.50
Beta0
11 Month Change5.00%
3 Month Change16.50%
1 Year Changen/a
33 Year Changen/a
5 Year Changen/a
Change since IPO22.27%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

7762TW BiotechsTW Market
7D-0.8%-1.2%-1.4%
1Yn/a-0.8%26.5%

Return vs Industry: Insufficient data to determine how 7762 performed against the TW Biotechs industry.

Return vs Market: Insufficient data to determine how 7762 performed against the TW Market.

Price Volatility

Is 7762's price volatile compared to industry and market?
7762 volatility
7762 Average Weekly Movement4.2%
Biotechs Industry Average Movement4.2%
Market Average Movement4.6%
10% most volatile stocks in TW Market8.0%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 7762 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: Insufficient data to determine 7762's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2011n/an/awww.petpharmbio.com

Pet Pharm Biotech Co., Ltd. manufactures and sells pharmaceutical products. The company also engages in the research, development, and production of nuclear medicine drugs. Its products include FDG fluodeoxyglucose, naolixi, and sodium fluoride injections; and radioactive sodium iodide capsules.

Pet Pharm Biotech Co., Ltd. Fundamentals Summary

How do Pet Pharm Biotech's earnings and revenue compare to its market cap?
7762 fundamental statistics
Market capNT$1.71b
Earnings (TTM)NT$0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
7762 income statement (TTM)
RevenueNT$0
Cost of RevenueNT$0
Gross ProfitNT$0
Other ExpensesNT$0
EarningsNT$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did 7762 perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

n/a

Payout Ratio